Anterior lumbar interbody fusion for treatment of failed back surgery syndrome: an outcome analysis.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 15028138.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Anterior lumbar interbody fusion (ALIF) has gained popularity for the treatment of degenerative disease of the lumbar spine. In this report, we present our experience with the ALIF procedure for treatment of failed back surgery syndrome (FBSS) in a noncontrolled prospective cohort. In a 2-year period, we treated patients diagnosed with FBSS with ALIF. Clinical and radiological outcomes were recorded in a prospective, nonrandomized, longitudinal manner. Neurological, pain, and functional outcomes were measured preoperatively and 12 months after surgery. Operative data, perioperative complications, and radiological and clinical outcomes were recorded. Thirty-three patients with a preoperative diagnosis of FBSS, with degenerative disc disease (n = 17), postsurgical spondylolisthesis (n = 13), or pseudarthrosis (n = 3), underwent ALIF. Back pain, leg pain, and functional status improved significantly, by 76% (P < 0.01), 80% (P < 0.01), and 67% (P < 0.01), respectively. On the basis of our results, we found ALIF to be a safe and effective procedure for the treatment of FBSS for selected patients.
Medical subject headings
- Low Back Pain
- Lumbar Vertebrae
- Postoperative Complications
- Pseudarthrosis
- Radiculopathy
- Spinal Fusion
- Spinal Osteophytosis
- Spondylolisthesis